Universitätsklinikum Mannheim


Standort der Organisation:
Mannheim, Deutschland

Forschungsprojekte mit FAU-Wissenschaftlern

PD Dr. Maria Neuss-Radu
(15.10.2015 - 28.02.2019)

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 2 von 4 Go to next page Go to last page
Krug, D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2018). Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment. Strahlentherapie und Onkologie, 194(9), 797-805. https://dx.doi.org/10.1007/s00066-018-1329-8
Fokas, E., Fietkau, R., Hartmann, A., Hohenberger, W., Grützmann, R., Ghadimi, M.,... Roedel, C. (2018). Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Annals of Oncology, 29(7), 1521-1527. https://dx.doi.org/10.1093/annonc/mdy143
Hochhaus, A., Saussele, S., Baerlocher, G.M., Bruemmendorf, T.H., Burchert, A., La Rosee, P.,... Pfirrmann, M. (2018). Nilotinib Vs Nilotinib Plus Pegylated Interferon-alpha2b Induction and Nilotinib or Pegylated Interferon-alpha2b Maintenance Therapy for Newly Diagnosed BCR-ABL plus Chronic Myeloid Leukemia Patients in Chronic Phase: Interim Analysis of the Tiger (CML V)-Study. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Schaarschmidt, M.-L., Herr, R., Gutknecht, M., Wroblewska, K., Gerdes, S., Sticherling, M.,... Peitsch, W.K. (2018). Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare). Acta Dermato-Venereologica, 98(2), 200-205. https://dx.doi.org/10.2340/00015555-2834
Haverkamp, C., Ganslandt, T., Horki, P., Boeker, M., Dörfler, A., Schwab, S.,... Urbach, H. (2018). Regional Differences in Thrombectomy Rates : Secondary use of Billing Codes in the MIRACUM (Medical Informatics for Research and Care in University Medicine) Consortium. Clinical Neuroradiology. https://dx.doi.org/10.1007/s00062-017-0656-y
Rinaldetti, S., Rempel, E., Worst, T.S., Eckstein, M., Steidler, A., Weiss, C.A.,... Erben, P. (2018). Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening. Oncotarget, 9(40), 25935-25945. https://dx.doi.org/10.18632/oncotarget.25407
Kähler, K.C., Blome, C., Forschner, A., Gutzmer, R., Hauschild, A., Heinzerling, L.,... Augustin, M. (2018). The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians. Oncotarget, 9(40), 26217-26225. https://dx.doi.org/10.18632/oncotarget.25439
Maier, C., Lang, L., Storf, H., Vormstein, P., Bieber, R., Bernarding, J.,... Sedlmayr, M. (2018). Towards Implementation of OMOP in a German University Hospital Consortium. Applied clinical informatics, 9(1), 54-61. https://dx.doi.org/10.1055/s-0037-1617452
Dietzel, M., Kaiser, C., Pinker, K., Wenkel, E., Hammon, M., Uder, M.,... Baltzer, P. (2017). Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy. Breast Care, 12(4), 231-236. https://dx.doi.org/10.1159/000480226
Krug, D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2017). Current controversies in radiotherapy for breast cancer. Radiation Oncology, 12(1). https://dx.doi.org/10.1186/s13014-017-0766-3
Dietzel, M., Kaiser, C.G., Wenkel, E., Clauser, P., Uder, M., Schulz-Wendtland, R., & Baltzer, P.A.T. (2017). Differentiation of ductal carcinoma in situ versus fibrocystic changes by magnetic resonance imaging: are there pathognomonic imaging features? Acta Radiologica, 284185117690420. https://dx.doi.org/10.1177/0284185117690420
Kriegmayr, M., Bergen, T., Ritter, M., Mandel, P., Michel, M., Wittenberg, T., & Bolenz, C. (2017). Digital Mapping of the Urinary Bladder: Potential for Standardized Cystoscopy Reports. Urology, 104(104), 235-241. https://dx.doi.org/10.1016/j.urology.2017.02.019
Kehl, S., Weiss, C., Dammer, U., Baier, F., Faschingbauer, F., Beckmann, M.,... Pretscher, J. (2017). Effect of Premature Rupture of Membranes on Induction of Labor: A Historical Cohort Study. Geburtshilfe und Frauenheilkunde, 77(11), 1174-1181. https://dx.doi.org/10.1055/s-0043-121007
Breyer, J., Otto, W., Wirtz, R.M., Wullich, B., Keck, B., Erben, P.,... Hartmann, A. (2017). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis, 98(3), 282-289. https://dx.doi.org/10.1159/000453670
Dovern, J., & Hartmann, M. (2017). Forecast performance, disagreement, and heterogeneous signal-to-noise ratios. Empirical Economics, 53(1), 63-77. https://dx.doi.org/10.1007/s00181-016-1137-x
Breyer, J., Wirtz, R.M., Otto, W., Erben, P., Kriegmair, M.C., Stoehr, R.,... Hartmann, A. (2017). In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Archiv, 470(3), 267-274. https://dx.doi.org/10.1007/s00428-017-2064-8
Cosgarea, ., Zimmer, L., Weide, B., Gutzmer, R., Heinzerling, L., Weishaupt, C.,... Ugurel, S. (2017). Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients. (pp. 16-17).
Middeke, J.M., Herbst, R., Parmentier, S., Bug, G., Hänel, M., Stuhler, G.,... Schetelig, J. (2017). Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial. Biology of Blood and Marrow Transplantation, 23(9), 1491-1497. https://dx.doi.org/10.1016/j.bbmt.2017.05.014
Mellinghoff, S.C., Panse, J., Alakel, N., Behre, G., Buchheidt, D., Christopeit, M.,... Cornely, O.A. (2017). Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Annals of Hematology. https://dx.doi.org/10.1007/s00277-017-3196-2
Heppt, M., Heinzerling, L., Kaehler, K., Forschner, A., Kirchberger, M., Loquai, C.,... Berking, C. (2017). Prognostic factors and outcomes in metastatic uveal melanoma treated with PD-1 or combined PD-1 / CTLA-4 inhibition. (pp. 14-14).

Zuletzt aktualisiert 2016-30-05 um 08:46